In a bold move to reduce U.S. prescription drug prices, AstraZeneca and Pfizer have struck deals with the White House, promising significant discounts for patients. This comes amid rising pressure from President Trump on drugmakers to lower costs or face hefty tariffs. Will these changes truly benefit American patients?
As federal subsidies for health insurance face expiration, Idaho residents like Susan Wood warn of skyrocketing premiums and potential loss of coverage. Thousands could be affected as Congress debates the future of healthcare funding.
Get ready for a smooth COVID-19 vaccine season! The CDC confirms access for everyone aged 6 months and older, with no prescription required. Discover what to expect and how to get your shot easily this year.
President Trump is set to unveil a new strategy to lower drug costs, including the launch of a 'TrumpRx' website for discounted medications and a deal with Pfizer. This move aims to tackle high prescription prices that burden American patients.
Many older Americans on Medicare are shocked to find that the newly approved Covid shots aren't covered, leading to hefty out-of-pocket expenses. Health officials claim coverage should be available, but patients report otherwise. What's going on?
As Social Security and Medicare trust funds face insolvency by 2034, experts warn that bond market pressures could force Congress into painful fiscal reforms. Will lawmakers finally tackle the 'third rail' of politics?
In a surprising move, Warren Buffett's Berkshire Hathaway invests $1.6 billion in UnitedHealth Group, a stock down 40% this year. Can this gamble pay off amid turmoil?
UnitedHealth Group's stock continues to decline as the insurer battles rising medical costs and a challenging earnings outlook. Following the abrupt CEO change, the company anticipates no earnings growth until 2026.
UnitedHealth Group's upcoming earnings report has sparked intense social media buzz as its stock faces a dramatic decline. Analysts weigh in on the potential for recovery or a value trap amid industry challenges.
A recent report reveals that the U.S. Social Security and Medicare programs will run short of funds by 2033, three years earlier than expected. As expenditures rise, lawmakers must act quickly to address looming financial challenges.
